Cellectis S.A. (EPA:ALCLS)
3.330
-0.080 (-2.35%)
Oct 20, 2025, 1:45 PM CET
Cellectis Employees
As of December 31, 2024, Cellectis had 222 total employees, including 216 full-time and 6 part-time employees. The number of employees increased by 1 or 0.45% compared to the previous year.
Employees
222
Change (1Y)
1
Growth (1Y)
0.45%
Revenue / Employee
€246,655
Profits / Employee
€229,388
Market Cap
246.63M
Employees Chart
Employees History
Date | Employees | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 222 | 1 | 0.45% |
Dec 31, 2023 | 221 | -16 | -6.75% |
Dec 31, 2022 | 237 | -63 | -21.00% |
Dec 31, 2021 | 300 | 19 | 6.76% |
Dec 31, 2020 | 281 | 17 | 6.44% |
Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
Company Name | Employees |
---|---|
EssilorLuxottica Société anonyme | 153,498 |
emeis Société anonyme | 83,494 |
Sanofi | 82,878 |
Eurofins Scientific SE | 62,696 |
Clariane SE | 61,798 |
bioMérieux | 14,754 |
Sartorius Stedim Biotech | 9,901 |
Virbac | 6,365 |
Cellectis News
- 2 days ago - CLLS: Analyst Raises Price Target Significantly for Cellectis | CLLS Stock News - GuruFocus
- 3 days ago - Cellectis' R&D Day Highlights Lasme-cel's Potential to Address Significant Unmet Need for Patients with r/r B-ALL - GlobeNewsWire
- 3 days ago - Top 2 Health Care Stocks That May Keep You Up At Night This Month - Benzinga
- 4 days ago - Cellectis Hosts R&D Day Today Showcasing Pipeline Progress and Long-Term Value Drivers - GlobeNewsWire
- 5 days ago - Allogene licensor Cellectis faces patent lawsuit in the U.S. - Seeking Alpha
- 13 days ago - Cellectis to Present Data on Non-Viral Gene Therapy and TALE Base Editors at the ESGCT Annual Congress - GlobeNewsWire
- 7 weeks ago - Top 5 Biotech Stocks With Strong Momentum - Benzinga
- 2 months ago - Cellectis S.A. (CLLS) Q2 2025 Earnings Call Transcript - Seeking Alpha